Methods of enhancing functioning of the large intestine
US6586399B1 · kind B1 · utility
31Cited by
3References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 20, 2000 |
| Grant date | Jul 1, 2003 |
| Priority date | — |
| Expiry date | Oct 20, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/605
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.